Halozyme Therapeutics, Inc. HALO
102.98 USD +0.06 (+0.06%)
At closeNov 10, 2026, 7:49 PM EST
101.26 -1.72 -1.67%
After hours · Nov 10, 7:49 PM ET
101.38 Day range 105.45
61.23 52-week range 134.00
- YTD
- +53.02%
- 1 year
- +51.42%
Held by funds
280 US ETFs and mutual funds hold HALO · largest positions
Ownership
Held by insiders 1.08%
Held by institutions 112.27%
Float held by institutions 113.49%
Institutions 984
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 11.64% | 13,271,095 | 1.37B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.69% | 5,351,312 | 551.08M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.65% | 5,299,008 | 545.69M | Jun 29, 2026 |
| State Street Corporation | 4.54% | 5,179,434 | 533.38M | Jun 29, 2026 |
| Invesco Ltd. | 2.79% | 3,177,997 | 327.27M | Jun 29, 2026 |
| Morgan Stanley | 2.48% | 2,832,594 | 291.70M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.55% | 4,042,836 | 416.33M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.30% | 3,762,787 | 387.49M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.39% | 2,721,119 | 280.22M | Jun 29, 2026 |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.47% | 1,679,285 | 172.93M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 1.37% | 1,566,912 | 161.36M | Jun 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.21% | 1,375,999 | 141.70M | Sep 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CONNAUGHTON BERNADETTE M. | Director | Sale | Aug 9, 2026 | 40,418 |
| DUNCAN BARBARA GAYLE | Director | Stock Award(Grant) | May 4, 2026 | 23,715 |
| HENDERSON JEFFREY WILLIAM | Director | Stock Award(Grant) | May 4, 2026 | 36,572 |
| LABARRE MICHAEL J. | Chief Technology Officer | Sale | Feb 26, 2025 | 173,756 |
| LABROSSE NICOLE | Chief Financial Officer | Conversion of Exercise of derivative security | Feb 22, 2026 | 38,494 |
| MATSUI CONNIE L | Director | Stock Gift | Nov 28, 2024 | 183,035 |
